Qianbin M. Li

Changsha, 410013, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

Discovery of 2, 4-disubstituted pyrimidine derivatives as selective HIPK2 inhibitors for potential treatment of chronic kidney disease.

Discovery of 2, 4-disubstituted pyrimidine derivatives as selective HIPK2 inhibitors for potential treatment of chronic kidney disease.

Journal: European journal of medicinal chemistry

Published: July 02, 2026

Identification of an Hsp110/HDAC6 Dual-Target Inhibitor for the Effective Treatment of Pulmonary Arterial Hypertension via Synergistic Blockade of Vascular Remodeling.

Identification of an Hsp110/HDAC6 Dual-Target Inhibitor for the Effective Treatment of Pulmonary Arterial Hypertension via Synergistic Blockade of Vascular Remodeling.

Journal: Journal of medicinal chemistry

Published: May 11, 2026

Identification of Nitric Oxide-Donating Lenumlostat Derivatives with Dual Activities of Extracellular Matrix Dysregulation Inhibition and Pulmonary Vasodilation for the Treatment of Pulmonary Arterial Hypertension.

Identification of Nitric Oxide-Donating Lenumlostat Derivatives with Dual Activities of Extracellular Matrix Dysregulation Inhibition and Pulmonary Vasodilation for the Treatment of Pulmonary Arterial Hypertension.

Journal: Journal of medicinal chemistry

Published: April 22, 2026

Efficacy and safety of emergency tevar for complicated type B aortic dissection with critical acute limb ischemia

Efficacy and safety of emergency tevar for complicated type B aortic dissection with critical acute limb ischemia

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: February 10, 2026

A Novel Dual URAT1/GLUT9 Inhibitor Reduces Hyperuricemia by Enhancing Uric Acid Excretion and Attenuating Renal Fibrosis.

A Novel Dual URAT1/GLUT9 Inhibitor Reduces Hyperuricemia by Enhancing Uric Acid Excretion and Attenuating Renal Fibrosis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 08, 2026

Ferroptosis inhibitors: latest advances and therapeutic potential for pulmonary arterial hypertension.

Ferroptosis inhibitors: latest advances and therapeutic potential for pulmonary arterial hypertension.

Journal: Drug discovery today

Published: January 06, 2026

Design and Optimization of LOXL2 and sGC Dual-Target Regulators Targeting Extracellular Matrix Dysregulation and Vasodilation for the Treatment of Pulmonary Arterial Hypertension.

Design and Optimization of LOXL2 and sGC Dual-Target Regulators Targeting Extracellular Matrix Dysregulation and Vasodilation for the Treatment of Pulmonary Arterial Hypertension.

Journal: Journal of medicinal chemistry

Published: December 13, 2025

Caveolin-1 Stabilizes SERCA2 to Counteract Acute Kidney Injury via Suppression of Ca2+-Dependent Endoplasmic Reticulum Stress in Distal Tubules.

Caveolin-1 Stabilizes SERCA2 to Counteract Acute Kidney Injury via Suppression of Ca2+-Dependent Endoplasmic Reticulum Stress in Distal Tubules.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 01, 2025

Discovery and research progress of CDK8 inhibitors.

Discovery and research progress of CDK8 inhibitors.

Journal: Biochemical pharmacology

Published: November 04, 2025

Insights into the cell type-specific susceptibility of kidney cells to ferroptosis.

Insights into the cell type-specific susceptibility of kidney cells to ferroptosis.

Journal: Drug discovery today

Published: November 02, 2025

Discovery of Cdc20/Hsp90 Dual-Target Inhibitors with Potent Antitumor Activity for Therapy of Acquired Resistant Melanoma.

Discovery of Cdc20/Hsp90 Dual-Target Inhibitors with Potent Antitumor Activity for Therapy of Acquired Resistant Melanoma.

Journal: Journal of medicinal chemistry

Published: October 17, 2025

Novel 2,4-thiazolidinedione derivatives as selective AMPKα1 activators for renal ischemia-reperfusion injury therapeutics.

Novel 2,4-thiazolidinedione derivatives as selective AMPKα1 activators for renal ischemia-reperfusion injury therapeutics.

Journal: European journal of medicinal chemistry

Published: October 06, 2025

Showing 1-12 of 77

Last Updated: 09/26/2026